2024 article

Updated ACVIM consensus statement on equine herpesvirus-1

Lunn, D. P., Burgess, B. A., Dorman, D. C., Goehring, L. S., Gross, P., Osterrieder, K., … Hussey, G. S. (2024, March 18). JOURNAL OF VETERINARY INTERNAL MEDICINE.

By: D. Lunn*, B. Burgess *, D. Dorman n, L. Goehring *, P. Gross n , K. Osterrieder *, N. Pusterla *, G. Hussey *

author keywords: abortion; diagnosis; equine; equine herpesvirus myeloencephalopathy; herpesvirus-1; rhinopneumonitis; therapy; vaccination; viremia
TL;DR: Evidence for successful vaccination against, or effective treatment of EHV-1 infection was limited, and improvements in experimental design and reporting of results are needed in future studies of this important disease. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: March 25, 2024

AbstractEquine herpesvirus‐1 (EHV‐1) is a highly prevalent and frequently pathogenic infection of equids. The most serious clinical consequences of infection are abortion and equine herpesvirus myeloencephalopathy (EHM). The previous consensus statement was published in 2009 and considered pathogenesis, strain variation, epidemiology, diagnostic testing, vaccination, outbreak prevention and control, and treatment. A recent survey of American College of Veterinary Internal Medicine large animal diplomates identified the need for a revision to this original consensus statement. This updated consensus statement is underpinned by 4 systematic reviews that addressed key questions concerning vaccination, pharmaceutical treatment, pathogenesis, and diagnostic testing. Evidence for successful vaccination against, or effective treatment of EHV‐1 infection was limited, and improvements in experimental design and reporting of results are needed in future studies of this important disease. This consensus statement also updates the topics considered previously in 2009.